Breaking News Instant updates and real-time market news.

MACK

Merrimack

$4.90

-0.06 (-1.21%)

, SHPG

Shire

$185.79

-1.91 (-1.02%)

11:07
10/18/16
10/18
11:07
10/18/16
11:07

Merrimack, Shire trade higher after EC grants MA for cancer treatment Onivyde

Shares of Merrimack Pharmaceuticals (MACK), a biopharmaceutical company that focuses on drugs to treat cancer, are higher in morning trading after PharmaEngine announced that the European Commission, or EC, granted Shire (SHPG), its sublicensee for Onivyde, a marketing authorization for the cancer treatment. WHAT'S NOTABLE: Onivyde, used in combination with 5-fluorouracil and leucovorin as a treatment for pancreatic cancer, was originally developed by Merrimack. Shire is responsible for development and marketing of the drug outside the United States and Taiwan and Merrimack markets Onivyde in the U.S. after the U.S. Food and Drug Administration approved it in October 2015. "We appreciate the joint team efforts from Merrimack and their licensee, Shire, for having submitted the Marketing Authorization Application to the EMA in May 2015, and successfully obtained the marketing approval," said C. Grace Yeh, Ph.D., President and CEO of PharmaEngine. "We are excited that Onivyde will now be available to treat the post-gemcitabine pancreatic cancer patients in the EU, which is one of the major markets that we licensed to Merrimack." PRICE ACTION: In morning trading, Merrimack Pharmaceuticals is up 4.5% to $5.12, while Shire is up 2.35% to $190.16.

MACK

Merrimack

$4.90

-0.06 (-1.21%)

SHPG

Shire

$185.79

-1.91 (-1.02%)

  • 26

    Oct

MACK Merrimack
$4.90

-0.06 (-1.21%)

08/05/16
BMUR
08/05/16
NO CHANGE
Target $13
BMUR
Buy
Merrimack price target lowered to $13 from $16 at Brean Capital
Brean Capital lowered its price target on Merrimack to $13 from $16 following Q2 results. The firm cited the sales miss on Onivyde, although they are encouraged by its early launch. Brean Capital reiterated its Buy rating on Merrimack shares.
08/05/16
COWN
08/05/16
DOWNGRADE
COWN
Market Perform
Merrimack downgraded to Market Perform from Outperform at Cowen
08/19/16
BTIG
08/19/16
INITIATION
BTIG
Neutral
Merrimack initiated with a Neutral at BTIG
BTIG analyst Ling Wang initiated Merrimack with a Neutral as he expects shares to be range-bound given the likely slow ramp-up of ONIVYDE and data from MM-302 and MM-121 won't be available until 2017 or beyond;
10/07/16
JPMS
10/07/16
DOWNGRADE
Target $7
JPMS
Neutral
Merrimack downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anupam Rama downgraded Merrimack Pharmaceuticals to Neutral saying the shares are likely to be range-bound after rallying 36% from the 52-week low on September 20. Key pipeline catalysts aren't likely until Q2 of 2017 and beyond while 2016 estimates are not "meaningfully beatable," Rama tells investors in a research note. He lowered his price target for the shares to $7 from $8.
SHPG Shire
$185.79

-1.91 (-1.02%)

08/03/16
LEER
08/03/16
NO CHANGE
Target $231
LEER
Outperform
Shire price target raised to $231 from $213 at Leerink
Leerink analyst Jason Gerberry raised his price target for Shire to $231 from $213 on valuation after the company reported "solid" Q2 results. The analyst reiterates an Outperform rating on the shares.
08/31/16
JEFF
08/31/16
NO CHANGE
Target $262
JEFF
Buy
Shire making right moves in dry eye market, says Jefferies
After hosting meetings with management, Jefferies analyst David Steinberg believes Shire (SHPG) is making "all the right moves" to make its dry eye drug Xiidra a potential $2B peak product in the U.S. Shire's Xiidra is competing with Allergan's (AGN) $1.4B dry eye drug Restasis, Steinberg tells investors in a research note. The analyst does not think Shire will have any problem exceeding the drug's consensus sales forecast of $200M for next year. He keeps a Buy rating on the shares with a $262 price target.
09/26/16
HSBC
09/26/16
DOWNGRADE
HSBC
Hold
Shire downgraded to Hold from Buy at HSBC
HSBC analyst Steve McGarry downgraded SHire to Hold saying valuation is no longer compelling.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

ATNM

Actinium Pharmaceuticals

$1.03

0.0344 (3.46%)

05:14
12/06/16
12/06
05:14
12/06/16
05:14
Hot Stocks
Actinium Pharmaceuticals presents Actimab-A Phase 1 study data at ASH »

Actinium Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BMRN

BioMarin

$82.45

0.24 (0.29%)

, ESALY

Eisai

$57.37

-0.545 (-0.94%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.45

0.24 (0.29%)

ESALY

Eisai

$57.37

-0.545 (-0.94%)

GWPH

GW Pharmaceuticals

$117.45

5.13 (4.57%)

IART

Integra LifeSciences

$76.78

1 (1.32%)

MDT

Medtronic

$71.67

-0.34 (-0.47%)

MNK

Mallinckrodt

$53.56

-0.05 (-0.09%)

NVTA

Invitae

$7.05

0.1 (1.44%)

SAGE

SAGE Therapeutics

$51.82

2.8 (5.71%)

WTKWY

Wolters Kluwer

$35.23

1.15 (3.37%)

ZGNX

Zogenix

$12.70

-0.35 (-2.68%)

ZYNE

Zynerba

$13.18

-0.46 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Productivity and Costs Unit labor costs to be reported at 08:30 »

Productivity and Costs…

ADSK

Autodesk

$71.18

0.61 (0.86%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Autodesk to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Jan

GWB

Great Western

$40.42

0.99 (2.51%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Great Western management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ECL

Ecolab

$118.56

1.67 (1.43%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Ecolab management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

CGNX

Cognex

$58.03

0.03 (0.05%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Cognex management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMCI

Super Micro Computer

$27.60

0.6 (2.22%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Super Micro Computer management to meet with Maxim »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Feb

  • 09

    Feb

LLL

L-3 Communications

$158.46

1.23 (0.78%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

CSV

Carriage Services

$27.79

0.29 (1.05%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Carriage Services management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Productivity and Costs Nonfarm productivity to be reported at 08:30 »

Productivity and Costs…

EKSO

Ekso Bionics

$4.67

0.4 (9.37%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Ekso Bionics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
American College of Neuropsychopharmacology to hold an annual meeting »

55th Annual Meeting of…

TWOU

2U

$32.15

0.99 (3.18%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Factory Orders to be reported at 10:00 »

October Factory Orders…

RGLS

Regulus

$2.85

0.35 (14.00%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Regulus to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

AGO

Assured Guaranty

$36.95

0.4 (1.09%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CHEF

Chefs' Warehouse

$14.10

0.9 (6.82%)

, SFS

Smart & Final Stores

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Barclays to hold a conference »

2016 Eat, Sleep, Play:…

CHEF

Chefs' Warehouse

$14.10

0.9 (6.82%)

SFS

Smart & Final Stores

SAFM

Sanderson Farms

$85.90

3.94 (4.81%)

JACK

Jack in the Box

$108.24

1.09 (1.02%)

CAKE

Cheesecake Factory

$61.40

0.92 (1.52%)

KR

Kroger

$32.93

-0.37 (-1.11%)

YUM

Yum! Brands

$63.06

0.64 (1.03%)

SYY

Sysco

$53.48

-0.11 (-0.21%)

RLJ

RLJ Lodging Trust

$23.38

0.86 (3.82%)

RCL

Royal Caribbean

$81.05

1.49 (1.87%)

PENN

Penn National

$13.50

0.13 (0.97%)

MGM

MGM Resorts

$28.97

-0.04 (-0.14%)

MAR

Marriott

$81.00

1.8 (2.27%)

LVS

Las Vegas Sands

$61.12

0.13 (0.21%)

HT

Hersha Hospitality

$20.75

0.19 (0.92%)

EAT

Brinker

$53.43

0.15 (0.28%)

DPZ

Domino's Pizza

$166.29

-1.71 (-1.02%)

CMG

Chipotle

$396.27

-3.76 (-0.94%)

CHH

Choice Hotels

$52.75

0.85 (1.64%)

BOJA

Bojangles

$18.75

0.65 (3.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 13

    Dec

  • 15

    Dec

  • 09

    Jan

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
KeyBanc to hold a conference »

Consumer Conference is…

ON

ON Semiconductor

$11.23

0.11 (0.99%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ECOM

ChannelAdvisor

$14.30

0.25 (1.78%)

, BCOV

Brightcove

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Raymond James to hold a conference »

Technology Investors…

ECOM

ChannelAdvisor

$14.30

0.25 (1.78%)

BCOV

Brightcove

EXTR

Extreme Networks

$4.43

0.15 (3.50%)

CTRL

Control4

$11.19

0.07 (0.63%)

JNPR

Juniper

$26.93

0.1 (0.37%)

SNX

SYNNEX

$121.70

2.97 (2.50%)

GIG

GigPeak

$2.62

0.15 (6.07%)

QRVO

Qorvo

$52.48

1.94 (3.84%)

FLEX

Flex

$14.55

0.17 (1.18%)

WK

Workiva

BNFT

Benefitfocus

$28.20

1.1 (4.06%)

HAR

Harman

$109.66

0.19 (0.17%)

FIT

Fitbit

$8.03

-0.11 (-1.35%)

ULTI

Ultimate Software

$192.96

1.56 (0.82%)

CRTO

Criteo

$39.33

0.65 (1.68%)

MSCC

Microsemi

$53.40

0.45 (0.85%)

VC

Visteon

$79.86

0.05 (0.06%)

ADI

Analog Devices

$70.60

0.49 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 13

    Dec

  • 14

    Dec

  • 05

    Jan

  • 10

    Jan

  • 14

    Feb

APTS

Preferred Apartment

$13.48

0.07 (0.52%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Preferred Apartment management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PLNT

Planet Fitness

$20.17

0.15 (0.75%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Planet Fitness management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Jan

SUM

Summit Materials

$23.53

0.27 (1.16%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Summit Materials management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 19

    Dec

CSIQ

Canadian Solar

$11.79

0.72 (6.50%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Canadian Solar management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.